IFF Events Mobile App
Issuu web publications
Order IFF materials
Order IFF Newsletter:
Instructions for players using asthma medication
Permitted Asthma medication
Salbutamol, salmeterol and formoterol are permitted in competition and out of competition in dosages considered to be appropriate for the treatment of asthma.
The use of salbutamol, provided the level in the urine is less than 1000 ng/ml (dosage guideline max. 1600 µg/24 h), salmeterol by inhalation (should be used in accordance with the manufacturers“ recommended therapeutic regime) and formoterol by inhalation (max. dose 54 micrograms (µg) over 24 hours) do not require a TUE. These substances when used in other ways, for example orally (tablets), are still prohibited and require TUEs.
Inhaled glucocorticosteroids are permitteddo not require a Therapeutic Use Exemption (TUE)-
Asthma medication requiring a TUE
Some Beta-2 agonists e.g. terbutaline is prohibited and require a Therapeutic Use Exemption (TUE). The request for a TUE should include a complete medical file with a clear explanation of why an alternate medication is being prescribed.
Summary of requirements for the medical file in case of asthma (attach to TUE application):
Examples of Beta-2 agonists including terbutaline: Bricanyl and Terbasmin.